MAPT and Alzheimer disease: Cerebrospinal fluid (CSF) tau protein and Aβ have been identified as biomarkers of AD; however, patients and their families often do not agree to CSF extraction for early diagnosis and screening of AD because of its invasive nature [6, 8].